Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Albrecht Stenzinger, MD"'
Autor:
Timothy Rajakumar, MD, PhD, Rastislav Horos, PhD, Paul Kittner, BSc, Mustafa Kahraman, PhD, Tobias Sikosek, PhD, Franziska Hinkfoth, MSc, Kaja Tikk, PhD, Nathaniel D. Mercaldo, PhD, Albrecht Stenzinger, MD, Klaus F. Rabe, MD, PhD, Martin Reck, MD, Michael Thomas, MD, Petros Christopoulos, MD, PhD, Bruno R. Steinkraus, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 8, Pp 100369- (2022)
Introduction: Patients with advanced, non-oncogene-driven NSCLC with high programmed death-ligand 1 (PD-L1) expression are eligible for treatment with immunotherapy. There is, however, an urgent medical need for biomarkers identifying cases that requ
Externí odkaz:
https://doaj.org/article/b983e5c58aea48b7bee928739fa6ad4a
